Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).
作者信息
Taylor Holly A, Dowdy David W, Searle Alexandra R, Stennett Andrea L, Dukhanin Vadim, Zwerling Alice A, Merritt Maria W
机构信息
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N Broadway, Baltimore, MD 21205 USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, Maryland 21205 USA.
出版信息
SSM Qual Res Health. 2022 Dec;2. doi: 10.1016/j.ssmqr.2022.100042. Epub 2022 Jan 28.
Abstract
摘要
相似文献
1
Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).
SSM Qual Res Health. 2022 Dec;2. doi: 10.1016/j.ssmqr.2022.100042. Epub 2022 Jan 28.
2
Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
Microbiol Spectr. 2021 Dec 22;9(3):e0040921. doi: 10.1128/Spectrum.00409-21. Epub 2021 Dec 1.
3
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
BMC Infect Dis. 2017 Aug 16;17(1):573. doi: 10.1186/s12879-017-2662-8.
4
Risk Factors for Multidrug-resistant Tuberculosis.
Acta Med Indones. 2018 Jan;50(1):1-2.
5
Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia.
BMC Public Health. 2018 Apr 2;18(1):422. doi: 10.1186/s12889-018-5371-3.
6
The Evolution and Transmission Dynamics of Multidrug-Resistant Tuberculosis in an Isolated High-Plateau Population of Tibet, China.
Microbiol Spectr. 2023 Mar 13;11(2):e0399122. doi: 10.1128/spectrum.03991-22.
7
More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.
Int J Mycobacteriol. 2016 Sep;5(3):324-327. doi: 10.1016/j.ijmyco.2016.07.007. Epub 2016 Aug 5.
8
[Multidrug-resistant tuberculosis. Additional comment: primary multidrug-resistant tuberculosis--diagnosis and treatment].
Kekkaku. 1998 Nov;73(11):687-90.
9
Genotyping and molecular detection of multidrug-resistant among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia.
New Microbes New Infect. 2017 Oct 24;21:36-41. doi: 10.1016/j.nmni.2017.10.009. eCollection 2018 Jan.
10
Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities.
Int J Infect Dis. 2017 Mar;56:194-199. doi: 10.1016/j.ijid.2016.11.423. Epub 2016 Dec 9.
引用本文的文献
1
Recent advancements in drug development for pulmonary tuberculosis.
Arch Microbiol. 2025 Aug 30;207(10):245. doi: 10.1007/s00203-025-04415-y.
2
Experiences of children and their caregivers affected by multidrug-resistant tuberculosis in Cape Town, South Africa.
PLoS One. 2025 May 19;20(5):e0323492. doi: 10.1371/journal.pone.0323492. eCollection 2025.
3
Non-inferiority stepped wedge cluster randomized controlled trial on all-oral shorter regimens for rifampicin resistant/multidrug-resistant TB in Pakistan - a study protocol.
BMC Infect Dis. 2025 May 7;25(1):674. doi: 10.1186/s12879-025-11068-1.
4
A Chronicle Review of Approaches for Discovering Novel Antimicrobial Agents to Combat Antimicrobial Resistance.
Indian J Microbiol. 2024 Sep;64(3):879-893. doi: 10.1007/s12088-024-01355-x. Epub 2024 Jul 22.
5
Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses.
Pharmacoeconomics. 2024 Nov;42(11):1209-1236. doi: 10.1007/s40273-024-01410-x. Epub 2024 Aug 7.
6
A health promotion model-based intervention to enhance treatment adherence in patients with type 2 diabetes.
BMC Public Health. 2024 Jul 19;24(1):1943. doi: 10.1186/s12889-024-19452-3.
本文引用的文献
1
'She is like my mother': Community-based care of drug-resistant tuberculosis in rural Eswatini.
Glob Public Health. 2021 Jun;16(6):911-923. doi: 10.1080/17441692.2020.1808039. Epub 2020 Aug 20.
2
Major Depression and Stigma among Individuals with Multidrug-Resistant Tuberculosis in South Africa.
Am J Trop Med Hyg. 2020 Sep;103(3):1067-1071. doi: 10.4269/ajtmh.19-0426.
3
"Death is a better option than being treated like this": a prevalence survey and qualitative study of depression among multi-drug resistant tuberculosis in-patients.
BMC Public Health. 2020 Jun 3;20(1):848. doi: 10.1186/s12889-020-08986-x.
4
Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis.
MDM Policy Pract. 2020 Apr 26;5(1):2381468320915239. doi: 10.1177/2381468320915239. eCollection 2020 Jan-Jun.
5
The prevalence of depression among patients with tuberculosis: a systematic review and meta-analysis.
Ann Gen Psychiatry. 2020 May 7;19:30. doi: 10.1186/s12991-020-00281-8. eCollection 2020.
6
Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.
Int J Tuberc Lung Dis. 2020 Jan 1;24(1):65-72. doi: 10.5588/ijtld.19.0062.
7
Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis.
Int J Tuberc Lung Dis. 2019 Jan 1;23(1):73-81. doi: 10.5588/ijtld.18.0149.
8
Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for .
Public Health Ethics. 2018 Jul 18;11(3):275-292. doi: 10.1093/phe/phy013. eCollection 2018 Nov.
9
The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study.
Trop Med Int Health. 2018 Jun;23(6):668-677. doi: 10.1111/tmi.13066. Epub 2018 May 16.
10
Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.
Indian J Tuberc. 2018 Jan;65(1):41-47. doi: 10.1016/j.ijtb.2017.05.003. Epub 2017 Jun 2.
Zotero 插件